
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitigation of evolved bacterial resistance to phage therapy
Clara Torres-Barceló, Paul E. Turner, Angus Buckling
Current Opinion in Virology (2022) Vol. 53, pp. 101201-101201
Open Access | Times Cited: 45
Clara Torres-Barceló, Paul E. Turner, Angus Buckling
Current Opinion in Virology (2022) Vol. 53, pp. 101201-101201
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Phage therapy: From biological mechanisms to future directions
Steffanie A. Strathdee, Graham F. Hatfull, Vivek K. Mutalik, et al.
Cell (2023) Vol. 186, Iss. 1, pp. 17-31
Open Access | Times Cited: 347
Steffanie A. Strathdee, Graham F. Hatfull, Vivek K. Mutalik, et al.
Cell (2023) Vol. 186, Iss. 1, pp. 17-31
Open Access | Times Cited: 347
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 61
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 61
Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance
Agnès Oromí-Bosch, Jyot D. Antani, Paul E. Turner
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 503-524
Open Access | Times Cited: 55
Agnès Oromí-Bosch, Jyot D. Antani, Paul E. Turner
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 503-524
Open Access | Times Cited: 55
The future of evolutionary medicine: sparking innovation in biomedicine and public health
Barbara Natterson-Horowitz, Athena Aktipis, Molly Fox, et al.
Frontiers in Science (2023) Vol. 1
Open Access | Times Cited: 31
Barbara Natterson-Horowitz, Athena Aktipis, Molly Fox, et al.
Frontiers in Science (2023) Vol. 1
Open Access | Times Cited: 31
Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University
Silvia Würstle, Alina Lee, Kaitlyn E. Kortright, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Silvia Würstle, Alina Lee, Kaitlyn E. Kortright, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Nucleus-forming jumbophage PhiKZ therapeutically outcompetes non-nucleus-forming jumbophage Callisto
Ampapan Naknaen, Thanadon Samernate, Panida Saeju, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109790-109790
Open Access | Times Cited: 8
Ampapan Naknaen, Thanadon Samernate, Panida Saeju, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109790-109790
Open Access | Times Cited: 8
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220121-220121
Open Access | Times Cited: 33
Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220121-220121
Open Access | Times Cited: 33
The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy
Jacopo Marchi, Sophia Zborowsky, Laurent Debarbieux, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106004-106004
Open Access | Times Cited: 20
Jacopo Marchi, Sophia Zborowsky, Laurent Debarbieux, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106004-106004
Open Access | Times Cited: 20
Epitopes in the capsular polysaccharide and the porin OmpK36 receptors are required for bacteriophage infection of Klebsiella pneumoniae
Rhys A. Dunstan, Rebecca S. Bamert, Kher Shing Tan, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112551-112551
Open Access | Times Cited: 20
Rhys A. Dunstan, Rebecca S. Bamert, Kher Shing Tan, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112551-112551
Open Access | Times Cited: 20
Strategies and mechanisms targeting Enterococcus faecalis biofilms associated with endodontic infections: a comprehensive review
Shipeng Yang, Xiuping Meng, Y. K. Zhen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Shipeng Yang, Xiuping Meng, Y. K. Zhen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Addressing the Research and Development Gaps in Modern Phage Therapy
Paul E. Turner, Joana Azeredo, Ed T. Buurman, et al.
PHAGE (2024) Vol. 5, Iss. 1, pp. 30-39
Open Access | Times Cited: 5
Paul E. Turner, Joana Azeredo, Ed T. Buurman, et al.
PHAGE (2024) Vol. 5, Iss. 1, pp. 30-39
Open Access | Times Cited: 5
Phage Therapy for Respiratory Infections: Opportunities and Challenges
Arya Khosravi, Qingquan Chen, Arne Echterhof, et al.
Lung (2024) Vol. 202, Iss. 3, pp. 223-232
Closed Access | Times Cited: 5
Arya Khosravi, Qingquan Chen, Arne Echterhof, et al.
Lung (2024) Vol. 202, Iss. 3, pp. 223-232
Closed Access | Times Cited: 5
Two virulent Vibrio campbellii phages with potential for phage therapy in aquaculture
Haifeng Ding, Keming Shi, Ming-Haung Hsiao, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Haifeng Ding, Keming Shi, Ming-Haung Hsiao, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens
Vivek K. Mutalik, Adam P. Arkin
iScience (2022) Vol. 25, Iss. 4, pp. 104121-104121
Open Access | Times Cited: 24
Vivek K. Mutalik, Adam P. Arkin
iScience (2022) Vol. 25, Iss. 4, pp. 104121-104121
Open Access | Times Cited: 24
Ecology and Evolutionary Biology of Hindering Phage Therapy: The Phage Tolerance vs. Phage Resistance of Bacterial Biofilms
Stephen T. Abedon
Antibiotics (2023) Vol. 12, Iss. 2, pp. 245-245
Open Access | Times Cited: 13
Stephen T. Abedon
Antibiotics (2023) Vol. 12, Iss. 2, pp. 245-245
Open Access | Times Cited: 13
Personalized Inhaled Bacteriophage Therapy Decreases Multidrug-ResistantPseudomonas aeruginosa
BK Chan, GL Stanley, KE Kortright, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
BK Chan, GL Stanley, KE Kortright, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy
Baptiste Gaborieau, Raphaëlle Delattre, Sandrine Adiba, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Open Access | Times Cited: 4
Baptiste Gaborieau, Raphaëlle Delattre, Sandrine Adiba, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Open Access | Times Cited: 4
A Klebsiella-phage cocktail to broaden the host range and delay bacteriophage resistance both in vitro and in vivo
Huanchang Chen, Haifeng Liu, Yanchun Gong, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Huanchang Chen, Haifeng Liu, Yanchun Gong, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Bacteriophage Effectively Rescues Pneumonia Caused by Prevalent Multidrug-Resistant Klebsiella pneumoniae in the Early Stage
Lin Gan, Hanyu Fu, Ziyan Tian, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 21
Lin Gan, Hanyu Fu, Ziyan Tian, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 21
Host immunity involvement in the outcome of phage therapy against hypervirulent Klebsiella pneumoniae infections
Miran Tang, Zhuocheng Yao, Yan Liu, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 3
Miran Tang, Zhuocheng Yao, Yan Liu, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 3
Development and application of CRISPR-based genetic tools in Bacillus species and Bacillus phages
Yafeng Song, Siqi He, Anita Jopkiewicz, et al.
Journal of Applied Microbiology (2022) Vol. 133, Iss. 4, pp. 2280-2298
Open Access | Times Cited: 17
Yafeng Song, Siqi He, Anita Jopkiewicz, et al.
Journal of Applied Microbiology (2022) Vol. 133, Iss. 4, pp. 2280-2298
Open Access | Times Cited: 17
Resistance-resistant antibacterial treatment strategies
Jonathan I. Batchelder, Patricia J. Hare, Wendy W. K. Mok
Frontiers in Antibiotics (2023) Vol. 2
Open Access | Times Cited: 8
Jonathan I. Batchelder, Patricia J. Hare, Wendy W. K. Mok
Frontiers in Antibiotics (2023) Vol. 2
Open Access | Times Cited: 8
Lytic/Lysogenic Transition as a Life-History Switch
Joan Roughgarden
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Joan Roughgarden
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Super Shedding in Enteric Pathogens: A Review
Florent Kempf, Roberto M. La Ragione, Barbara Chirullo, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2101-2101
Open Access | Times Cited: 12
Florent Kempf, Roberto M. La Ragione, Barbara Chirullo, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2101-2101
Open Access | Times Cited: 12
Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy
Sixuan Lv, Yuhan Wang, Kaixin Jiang, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1736-1736
Open Access | Times Cited: 7
Sixuan Lv, Yuhan Wang, Kaixin Jiang, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1736-1736
Open Access | Times Cited: 7